72,234 articles
MDA-MB-231
MDA-MB-231 (MD Anderson-Metastatic Breast-231, RRID:CVCL_0062) is a triple-negative human breast adenocarcinoma cell line established in 1973 from a pleural effusion, widely used in metastatic breast cancer and drug screening research.
MDA-MB-361
MDA-MB-361 (ATCC HTB-27, CVCL_0620) is a human luminal B, ER+/HER2+ breast adenocarcinoma cell line established in 1978 from a brain metastasis of a 40-year-old woman, carrying PIK3CA and TP53 mutations.
MDA-MB-435
MDA-MB-435 is a human cancer cell line established in 1976 as a breast carcinoma line, later shown by genetic testing to be a melanoma line derived from M14.
MDA-MB-435S
MDA-MB-435S (CVCL_0622, ATCC HTB-129), also called MDA-MB-435s or BrCL15, is a human cancer cell line long used as a breast cancer model but shown by STR authentication to be a misidentified derivative of the M14 melanoma line, carrying BRAF V600E.
MDA-MB-436
MDA-MB-436 (MD Anderson-Metastatic Breast-436, CVCL_0623, ATCC HTB-130) is a triple-negative, BRCA1-mutant (c.5277+1G>A) human breast cancer cell line from a 1978 pleural effusion metastasis, used as a Basal B/mesenchymal TNBC and chemoresistance model.
MDA-MB-453
MDA-MB-453 (CVCL_0418, ATCC HTB-131) is a human breast cancer cell line established in 1976 from a pericardial effusion, ER−/PR−, androgen receptor-positive and HER2-positive, used for androgen receptor and HER2 research.
MDA-MB-468
MDA-MB-468 (ATCC HTB-132, CVCL_0419) is a human triple-negative, basal-like breast cancer cell line isolated in 1977 from a pleural effusion of a 51-year-old Black female donor, carrying TP53 R273H, PTEN loss, and amplified EGFR.
MDBK
MDBK (Madin-Darby Bovine Kidney, NBL-1, ATCC CCL-22) is a bovine kidney epithelial cell line established in 1957 by Madin and Darby, widely used for propagating bovine viruses and as a transfection host.
MDC1
MDC1 (NFBD1, mediator of DNA damage checkpoint 1) is a 2,089-residue human scaffold protein that binds γH2AX at DNA double-strand breaks, amplifies ATM signaling, recruits repair factors like 53BP1 and BRCA1, and acts as a tumor suppressor and nuclear receptor co-regulator.
MDCK
MDCK, short for Madin-Darby Canine Kidney, is a dog kidney cell line established in 1958 that is the standard model for epithelial polarity and a substrate for influenza vaccines.
Mdm2
Mdm2 (double minute 2, Hdm2) is a RING E3 ubiquitin ligase and the main negative regulator of p53, binding its transactivation domain and driving its degradation; amplified in cancers and targeted by inhibitors such as brigimadlin and milademetan.
MDM4
MDM4 (MDMX, HDMX), gene ID 4194 at 1q32, encodes a 490-aa p53 negative regulator that heterodimerizes with MDM2 to drive p53 ubiquitination and has p53-independent roles in DNA repair and replication; overexpressed in about 20% of cancers.
MDMA-assisted psychotherapy
MDMA-assisted psychotherapy (MDMA-AT, midomafetamine) is an experimental PTSD treatment pairing supervised MDMA sessions with structured therapy; Phase 3 trials showed benefit, but the FDA declined approval in August 2024.
MDN2-binding protein
MDN2-binding protein (MDM2-binding protein, MTBP) is a nuclear protein that binds MDM2, drives DNA replication origin firing with Treslin/TICRR, acts as a MYC cofactor, and is overexpressed in cancers including triple negative breast cancer.
MDR-001
MDR-001: MindRank's AI-designed oral small-molecule GLP-1 receptor agonist (β-arrestin2-biased) for obesity and type 2 diabetes; Phase 2b showed 8-10% weight loss; Phase III MOBILE trial ongoing in China.
mdx mouse
The mdx mouse is a mutant laboratory mouse lacking the muscle protein dystrophin, the standard animal model of Duchenne muscular dystrophy, arising spontaneously in 1981 and described in 1984.
ME-180
ME-180 (ME180, ATCC HTB-33, CVCL_1401) is a human cervical epidermoid carcinoma cell line from a 66-year-old woman, HPV-positive (HPV68/39 reports), p53+/pRB+, PIK3CA-mutant, widely used in cervical cancer drug research.
Meacham syndrome
Meacham syndrome (Meacham-Winn-Culler syndrome), a very rare 46,XY disorder of sex development with ambiguous genitalia, diaphragmatic defects, complex congenital heart and lung malformations; 13 cases reported, WT1-related, poor prognosis.
Meadow
Meadow: grassland left uncut through the growing season, then mown for hay and aftermath-grazed, unlike year-round pasture. Flower-rich habitat; over 97% of UK hay meadows lost since the 1930s; also mountain and urban meadow types.
Mealworm
Mealworm: larva of the darkling beetle Tenebrio molitor (yellow mealworm), a worldwide grain pest also farmed for pet feed, animal feed, and EU-approved human food; distinct from the dark mealworm Tenebrio obscurus and superworm Zophobas morio.
Mealybug
Mealybug (Pseudococcidae), scale insect family of over 2,000 sap-sucking species with wax-covered females; pests like citrus mealybug Planococcus citri, controlled by Cryptolaemus and parasitoids.
Mean arterial pressure
Mean arterial pressure (MAP) is the average arterial pressure over the cardiac cycle, estimated as 1/3 systolic + 2/3 diastolic. Key targets: 65 mm Hg in septic shock; ambulatory thresholds <90/90-92/≥92 mmHg.
Mean corpuscular hemoglobin concentration
Mean corpuscular hemoglobin concentration (MCHC) is a red cell index, hemoglobin divided by packed cell volume, used in anemia classification and discriminant indices, with typical adult reference intervals near 31.9-35.5 g/dL.
Mean corpuscular volume
Mean corpuscular volume (MCV), or mean cell volume, is a CBC red cell index measuring average red blood cell size in femtoliters; normal adult range about 80-100 fL, classifying anemia as microcytic, normocytic, or macrocytic.
Mean platelet volume
Mean platelet volume (MPV) is the average platelet size in femtoliters from a routine blood count; healthy range 7.7–11.2 fL, inversely related to platelet count, sensitive to anticoagulant and analyzer, studied as a cardiovascular biomarker.
Measles
Measles (rubeola), a highly contagious morbillivirus infection with R0 12-18, airborne persistence up to 2 hours, immune amnesia, and 11 million estimated cases in 2024; prevented by two MMR doses (97% effective).
Measles and rubella vaccine, live, attenuated
Measles and rubella vaccine, live, attenuated (MR vaccine): freeze-dried bivalent live vaccine with Edmonston-Zagreb measles and Wistar RA 27/3 rubella strains, 1000 CCID50 each per 0.5 ml subcutaneous dose, WHO-prequalified since 2000.
Measles complicated by encephalitis
Measles complicated by encephalitis: brain inflammation from measles virus infection, about 1 per 1,000 cases, often causing permanent brain damage; includes ADEM, MIBE, and SSPE forms.
Measles vaccine
Measles vaccine, given as MMR or MMRV combination shots, is a live attenuated vaccine; two doses are 97% effective, with no evidence of autism risk and only small febrile seizure and ITP risks.
Measles vaccine, live, attenuated
Measles vaccine, live, attenuated (Edmonston-B, Edmonston-Enders strains; MMR/MMRV components): a live weakened measles virus vaccine licensed in 1963, 95% effective after one dose, 96% after two.